Artelo Biosciences, Inc. (ARTL): Total Liabilities
$4.07M
As of 2025-12-31
$1.46M
As of 2026-06-30
+58.6%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.07M | +121.2% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $1.84M | +42.6% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $1.29M | +26.4% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $1.02M | -5.8% | 2024-03-25, Balance as of period end |
| 2021-12-31 | $1.08M | n/a | 2023-03-31, Balance as of period end |
| 2021-08-31 | $593.0K | +18.4% | 2023-03-31, Balance as of period end |
| 2020-08-31 | $501.0K | n/a | 2021-11-29, Balance as of period end |
| No annual figure between 2016-08-31 and 2020-08-31. | |||
| 2016-08-31 | $17.4K | +900.0% | 2016-11-29, Balance as of period end |
| 2015-08-31 | $1.7K | n/a | 2016-11-29, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | $4.07M | +121.2% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $672.0K | +14.3% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $20.33M | +127.9% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $1.10M | +34.7% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $754.4K | +74.3% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $813.0K | +17.5% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $5.08M | -14.4% |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | $1.96M | -8.9% |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | $402.4K | -88.4% |
Compare ARTL, BFRG, NTHI, ATXI side by side · Screen every company in Pharmaceutical Preparations ↗